Ambee’s Post

There are different ways to protect against indoor allergies in the fall and winter, but the best way to prevent an allergic reaction is for patients to be tested, diagnosed, and treated at an allergy clinic. If your patients are interested in learning more about how allergies are diagnosed and treated, share our recent article with them: https://bit.ly/4bqIGgb #allergydiagnosis #allergytesting #allergytreatment

#Allergy to #HouseDustMite is a common cause of allergic reactions. There are several species of dust mites, but the most common ones associated with human allergies include Dermatophagoides pteronyssinus (European house dust mite) and Dermatophagoides farinae (American house dust mite), among others. 👉At Rekom Biotech, we offer validated and high-quality recombinant allergens for in vitro diagnosis of allergy to house dust mites. Do not hesitate to take a look at our website to find IVD reagents for your assay development! #RecombinantAllergens #RecombinantProteins #InVitroDiagnostics #IVD #GetREKOMended

Allergy season is here. 🤧 What are consumers talking about online? 💬 32.5% of allergy conversation focused on the rising cost of medication.  💊 There was a 23.5% surge in discussion surrounding allergy medicine from October 2023 to March 2024. This was sparked by recent shortages, warmer winters, and longer pollen seasons. 🍃 Consumers are increasingly seeking alternatives to conventional pharma solutions to manage their symptoms. Natural and holistic remedies are gaining popularity. What is causing this shift? What do pharma companies need to know? Storyful's Nazma Kazani shares the latest insights this allergy season: https://lnkd.in/eDa4ScCi #allergy #pharma #allergymedicine

Tired of just masking those miserable allergy symptoms with OTC meds? Are you ready to target the cause, and reduce or eliminate the sniffles permanently? Allergy immunotherapy is the closest thing to a cure. Learn more about allergy shots or drops and which might be best for you!

Allergy Awareness Week, observed from 𝐀𝐩𝐫𝐢𝐥 𝟐𝟐𝐧𝐝 𝐭𝐨 𝟐𝟖𝐭𝐡, 𝟐𝟎𝟐𝟒, is dedicated to increasing public understanding and awareness of allergic conditions. This year’s theme, ‘𝐶ℎ𝑖𝑙𝑑ℎ𝑜𝑜𝑑 𝐹𝑜𝑜𝑑 𝐴𝑙𝑙𝑒𝑟𝑔𝑖𝑒𝑠', aims to help parents and caregivers by providing practical support associated with their children’s allergies. The statistics by 𝑨𝒍𝒍𝒆𝒓𝒈𝒚𝑼𝑲 state that currently the country is in the top two for the highest cases of allergic eczema. Its predictions also infer that at least 𝟏 𝐢𝐧 𝟐 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧𝐬 will be affected with some allergy by 𝟐𝟎𝟐𝟔. These alarming numbers reflect the importance of empowering individuals with the right knowledge and tools to manage their allergies effectively. Hence, an early diagnosis can prevent severe allergic reactions, including anaphylaxis, and reducing long-term health complications. As awareness increases, the demand for diagnostic services, allergy tests, and subsequent treatment solutions also rises. This has led healthcare companies to closely monitor allergy trends and develop personalized medicine for more targeted treatments. Thus, improved patient outcomes lead to the expansion of the allergy diagnostic and treatment market. Upon analyzing this growth uptrend, the global market for allergy diagnostic and treatment is set to rise at a CAGR of 𝟓.𝟐𝟕% over the forecasted period 𝟐𝟎𝟏𝟗-𝟐𝟎𝟐𝟕. As we approach this important week, let us commit to enhancing our understanding regarding the timely management of allergies. Get more detailed insights on this market by requesting a FREE sample of the report here: https://lnkd.in/dtPyQ7cK . . . Mylan Hitachi Chemical Beckman Coulter Diagnostics Allergan #allergyawarenessweek #allergies #allergydiagnostic #allergytreatment #foodallergy #healthcare #marketanalysis #tritonmarketresearch

🚨 Breaking News in Allergy Emergency Treatment: Nasal Spray approval offers a Needle-Free option!🚨 The FDA has just approved Neffy, a groundbreaking nasal spray alternative to the EpiPen, offering a needle-free option for treating life-threatening allergic reactions, including anaphylaxis. This is a major advancement for those who struggle with needle anxiety, making emergency treatment more accessible and less intimidating. Interestingly, the FDA initially declined to approve Neffy last year despite a positive recommendation from an expert panel. The agency requested an additional study comparing repeat doses of Neffy to traditional epinephrine injections. ARS Pharmaceuticals, Inc. took on the challenge, conducted the study, and now, Neffy has secured its FDA approval. Neffy’s approval is based on rigorous studies showing that its effectiveness in delivering epinephrine is comparable to traditional auto-injectors. It’s designed for quick, easy administration—just a single spray into one nostril—with the option for a second dose if needed. With Neffy expected to be competitively priced and widely accessible, it’s poised to significantly reduce barriers to life-saving treatment for millions of people. This could be a game-changer for both patients and healthcare providers, offering a safer and more convenient way to manage severe allergic reactions. Read the full details in the article https://lnkd.in/gZ5dWUcB. If you found this post helpful, please share it with your network. Don’t forget to follow me for more insights like this! #FDAApproval #Neffy #Epinephrine #Anaphylaxis #HealthcareInnovation #MedicalDevices #AllergyTreatment #combinationproducts #medicaldevices

**Exciting News in Allergy Relief!** The FDA has approved the first nasal spray for severe allergic reactions, a groundbreaking development for millions of allergy sufferers. This new nasal spray, a quicker and more effective alternative to the traditional EpiPen, offers several key advantages. Firstly, **ease of use**; unlike EpiPens which require an injection, the nasal spray is administered simply by spraying into the nostrils. This is a non-invasive method that reduces the need for extensive training and minimizes the hesitation some might feel about self-injection. Secondly, **rapid action**; the nasal spray delivers medication directly to the bloodstream within minutes due to the rich network of blood vessels in the nasal cavity. Thirdly, **portability**; it's compact and easy to carry around, ensuring it's accessible in various situations. It's also more **cost-effective**, expected to be more affordable than EpiPens, which have been criticized for their high prices. Finally, **effectiveness**; clinical trials have demonstrated that the nasal spray is as effective as EpiPens in providing protection against severe allergic reactions. The science behind this innovative product revolves around epinephrine - the same active ingredient found in EpiPens. When delivered through the nasal cavity, it ensures rapid systemic absorption, providing immediate relief during severe allergic reactions. This method is especially beneficial for those with severe allergies, caregivers, teachers, and individuals with needle phobia. This approval marks a significant advancement in medical treatments for anaphylaxis, poised to improve the quality of life for many and potentially save lives. Enhanced accessibility and affordability could lead to better patient outcomes, reducing fatalities from allergic reactions. **Next steps? Set up a call with us at Together CFO:** **_https://lnkd.in/gNmSEaig

FDA says some cold and allergy drugs have an ineffective key ingredient ——————— New Concerns about Key Ingredient in Over-the-Counter Cold and Allergy Medicines The Food and Drug Administration (FDA) has announced that a common ingredient in many over-the-counter (OTC) cold and allergy medications is safe, but not effective in treating congestion and decongestion. This ingredient, called phenylephrine, can be found in a range of medications, including oral and nasal sprays used to treat cold and flu symptoms. What Meds is it Found In? Phenylephrine is a common ingredien... Read Full Article: https://lnkd.in/eDAeBWP3 #World #allergy #Cold #congestion #decongestion #doctor #FDA #fever #households #ingredients #live #manufacturers #Medication #medications #medicinecabinet #medicines #MorningNewsNOW #NasalSpray #NyQuil #pharmacist #phenylephrine #pseudoephedrine #Sudafed #SudafedPE #survey #symptoms #tradegroup #Tylenol

Are you looking for a way to explain the difference between Zyrtec and Claritin to your patients? Here, we outline the key differences between these two popular allergy medications. Share this with your patients so they can confidently make decisions about their allergy treatments. #pharmacy #pharmacist #zyrtec #claritin #allergies #allergymedication #rx #singlecare

Hoxb8 Mast Cell Activation Test Demonstrates Diagnostic Precision for Assessment of Peanut Allergy: When compared to established diagnostic assays such as the basophil activation test, the Hoxb8 mast cell activation test demonstrates similar precision. #finance #pharmacy #lifesciences